Vitamin D Supplementation among Deficient Indian Pregnant Women: A Study Protocol

Vitamin D, requirements during pregnancy increases to support maternal needs and additionally fetal development. While Vitamin D Deficiency (VDD) during pregnancy is reported globally, community-based studies in India indicate staggering VDD prevalence of 60-80%. Vitamin D supplementation, therefore, presents as a potential strategy to mitigate the risk of adverse pregnancy and birth outcomes (such as, pre-eclampsia, pre-term birth, gestational diabetes, and low birth weight). Previous research also suggests that maternal vitamin D supplementation during pregnancy may confer long-term health benefits to the offspring. Thus, the study aim to test whether a higher dose of vitamin D3 supplementation (2000 IU/day) given during pregnancy repletes deficient Indian pregnant women while ensuring safety concerning hypervitaminosis-D. Additionally, we intend to assess if this repletion influences the immune profile of the newborn. An open-label intervention of 2000IU of vitamin D3/day to pregnant women (N=200) with VDD, starting at recruitment (≤14 weeks of gestation) and continued until delivery. Participant screening, informed consent, and recruitment will happen at the out-patient department of the Obstetrics department of St. John’s Medical College Hospital, Bengaluru, India. Women presenting with chronic morbidities (such as, hypertension, diabetes, metabolic syndrome), undergoing medications/treatment, with known infections such as HIV, VDRL, HBsAg), conceiving through assisted reproduction, and anticipating to move out of study site before the closure of the study will be excluded. This study will provide evidence towards the safety and effectiveness of this supplemental dose of vitamin D3 in improving vitamin D status of Indian pregnant women. Further, it will bridge research gaps related to the rationale and justification for early and daily implementation of vitamin D supplementation.

View article page

Download PDF